RecruitingPhase 4NCT06902285

Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty

Use of Magnesium-L-Threonate to Improve Subjective Sleep Quality After Total Joint Arthroplasties: Randomized Controlled Clinical Trial


Sponsor

University of Miami

Enrollment

64 participants

Start Date

Apr 21, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The study team is conducting a study to see if Magnesium-L-Threonate (MgT) can help improve how well participants sleep and reduce pain after total joint replacement surgery


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Control and a drug called Magnesium Threonate for people with knee osteoarthritis and sleep. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMagnesium Threonate

Participants will receive a daily 145 mg pill by mouth 30 minutes before going to sleep

OTHERControl

Participants will receive two sugar pills daily by mouth 30 minutes before going to sleep


Locations(1)

University of Miami Hospital

Miami, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06902285


Related Trials